| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |